Treasuries slid and the US dollar climbed after stronger-than-expected jobs numbers dampened Wall Street’s confidence that the Federal Reserve’s next interest-rate cut would be a…
Sales in the fiscal third quarter, which ended August 25, were slightly short of the average analyst estimate, while Levi’s Americas division posted a revenue…
Lenacapavir is a US Food and Drug Administration (FDA) approved medication indicated for the treatment of HIV type 1 (HIV-1) infection in heavily treatment-experienced adults…
The partnership will prioritise green energy generation, focusing on solar and hydropower initiatives while also exploring innovative green technologies.
Ed Yardeni, President of Yardeni Research, expressed doubts about the effectiveness of China’s efforts to revive its struggling real estate market.
Thursday will also be the weekly options expiry of the Nifty contracts and business updates for companies will continue as usual.
Zydus Lifesciences has received tentative approval from the US Food and Drug Administration (USFDA) to manufacture Enzalutamide tablets (40 mg and 80 mg), the drug…
Peak XV Partners said despite resizing vintage fund it would remain highly committed to investing in India and Southeast Asia, driven by strong portfolio performance…
Jefferies’ Chris Wood said a deterioration in the geopolitical situation is the biggest risk to global equity markets.
Nike has been known for its innovation but in recent years, analysts have said that it has lost its focus on coming up with cool…